Compare ABCL & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | COLD |
|---|---|---|
| Founded | 2012 | 1903 |
| Country | Canada | United States |
| Employees | N/A | 12690 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.0B |
| IPO Year | 2020 | 2009 |
| Metric | ABCL | COLD |
|---|---|---|
| Price | $9.66 | $16.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 17 |
| Target Price | ★ $18.69 | $16.71 |
| AVG Volume (30 Days) | 2.8M | ★ 4.9M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.63% |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | $75,128,000.00 | ★ $2,601,846,000.00 |
| Revenue This Year | N/A | $0.14 |
| Revenue Next Year | $13.74 | N/A |
| P/E Ratio | ★ N/A | $14.33 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $10.28 |
| 52 Week High | $14.98 | $16.92 |
| Indicator | ABCL | COLD |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 61.90 |
| Support Level | $3.45 | $13.70 |
| Resistance Level | $12.91 | $16.88 |
| Average True Range (ATR) | 0.84 | 0.53 |
| MACD | -0.22 | 0.05 |
| Stochastic Oscillator | 2.41 | 74.26 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.